Association of Anti-Smith, Anti-Ro, and Anti-ribonucleoprotein Combination With Accelerated Development of Lupus Nephritis in Systemic Lupus Erythematosus Patients in Saudi Arabia
2024

Antibody Profile and Lupus Nephritis Risk in Saudi Patients

Sample size: 128 publication 10 minutes Evidence: moderate

Author Information

Author(s): Muacevic Alexander, Adler John R, Alsalman Ahmed, Albalawi Taraq, Albalwi Faisael, Albirdisi Majed

Primary Institution: King Fahad Medical City, Riyadh, SAU

Hypothesis

Is there an association between the presence of anti-Smith, anti-Ro, and anti-RNP antibodies and the development of lupus nephritis in systemic lupus erythematosus patients?

Conclusion

The presence of anti-Sm, anti-Ro, and anti-RNP antibodies is associated with a higher risk of early lupus nephritis development within five years after initial SLE diagnosis.

Supporting Evidence

  • 95% of patients with all three antibodies developed proteinuria within the first five years of SLE diagnosis.
  • Patients with positive antibody profiles had a higher likelihood of developing lupus nephritis earlier.
  • The study included a representative cohort reflective of routine clinical practice.

Takeaway

If you have certain antibodies, you might get kidney problems from lupus faster than others.

Methodology

A retrospective, single-center cohort study analyzing 128 SLE patients with lupus nephritis, focusing on antibody profiles and time to proteinuria development.

Potential Biases

Potential biases include recall bias and incomplete records due to the retrospective nature of the study.

Limitations

The study's retrospective design and small sample size limit the ability to establish causative relationships.

Participant Demographics

The majority of participants were Saudi (96.88%), with a median age of 30.5 years, predominantly female (85.94%).

Statistical Information

P-Value

0.0033

Confidence Interval

95% CI: 4.793-9.798

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.7759/cureus.75917

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication